Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Syndax Pharmaceuticals, Inc. (SNDX)

Pharmaceutical Preparations

https://www.syndax.com

Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3
WALTHAM, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/03/2016

Market Cap

1,700,651,554

Shares Outstanding

80,450,000

Weighted SO

84,809,736

Total Employees

N/A

Upcoming Earnings

N/A

Beta

0.9390

Last Div

0.0000

Range

11.215-25.34

Chg

0.0250

Avg Vol

1116283

Mkt Cap

1700651554

Exch

NASDAQ

Country

US

Phone

781 419 1400

DCF Diff

15.8955

DCF

4.1745

Div Yield

0.0000

P/S

421.3706

EV Multiple

-5.6512

P/FV

3.9237

Div Yield %

0.0000

P/E

-6.4534

PEG

0.2507

Payout

0.0000

Current Ratio

10.5024

Quick Ratio

10.5024

Cash Ratio

2.4815

DSO

984.1254

DIO

0.0000

Op Cycle

984.1254

DPO

15409.9270

CCC

-14425.8016

Gross Margin

0.9321

Op Margin

-71.3553

Pretax Margin

-65.4316

Net Margin

-65.4316

Eff Tax Rate

-0.0187

ROA

-0.5537

ROE

-0.5742

ROCE

-0.6628

NI/EBT

1.0000

EBT/EBIT

0.9170

EBIT/Rev

-71.3553

Debt Ratio

0.0021

D/E

0.0023

LT Debt/Cap

0.0000

Total Debt/Cap

0.0023

Int Coverage

-95996.6667

CF/Debt

-242.8953

Equity Multi

1.0981

Rec Turnover

0.3709

Pay Turnover

0.0237

Inv Turnover

0.0000

FA Turnover

4.0279

Asset Turnover

0.0085

OCF/Share

-2.8284

FCF/Share

-2.8284

Cash/Share

4.9850

OCF/Sales

-59.7609

FCF/OCF

1.0000

CF Coverage

-242.8953

ST Coverage

-242.8953

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

3.9237

P/B

3.9237

P/S

421.3706

P/E

-6.4534

P/FCF

-7.0509

P/OCF

-7.0657

P/CF

-7.0657

PEG

0.2507

P/S

421.3706

EV Multiple

-5.6512

P/FV

3.9237

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation